The United States is facing an increase in human infections by drug-resistant bacteria. One such bacteria, called New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales, is ...
Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...
A team of biomedical engineers from Brown University has created a new wound dressing material that releases antibiotic drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results